TY - JOUR AU - B. M. Gumeniuk AU - V. V. Popov PY - 2020/01/27 Y2 - 2024/03/29 TI - Bloodless Operations in the Surgical Treatment of Mitral-Aortic Heart Disease in Conditions of Artificial Circulation JF - Ukrainian Journal of Cardiovascular Surgery JA - ujcvs VL - IS - 1 (38) SE - ACQUIRED HEART DISEASES DO - 10.30702/ujcvs/20.3803/006032-036 UR - http://cvs.org.ua/index.php/ujcvs/article/view/332 AB - Traditional mitral and aortic valve replacement in conditions of artificial blood circulation (ABC) involves the use of blood products. Given various complications arising in perioperative period, the authors propose a technique for “bloodless operations” without the use of donor blood, without the use of columns, and the “sell-saver” method. From January 1, 2011 to December 31, 2018, mitral-aortic valve replacement was performed in 79 patients; in 42 of them blood products were used during surgery, and in 37 patients donor blood components were not used. The method of anaesthetic and infusion-perfusion measures for mitral-aortic valve replacement in conditions of ABC is given. The use of the blood-saving method has allowed to obtain good clinical effect without transfusion complications in perioperative period, which facilitated the use of bloodless methods for mitral-aortic valve replacement in the main group in conditions of ABC and reduce blood transfusions in perioperative period from 27.4 % to 10.3 % of the circulating blood volume (CBV), compared to the control group. In the variant of reservation of autoblood “A+B+C” and exfusion of 27.2% of the CBV, the most effective variants of the blood-saving) technology were observed during mitral-aortic valve repair in conditions of ABC. ER -